Pharma Stocks Outlook for the week – 08 to 12.06.2015
(Seen
negative on weak earnings)
( www.rupeedesk.in )
Following
weak results for the quarter ended March; shares of most pharmaceutical
companies are seen trading down next week, with those of Sun Pharmaceutical
Industries Ltd witnessing the highest loss of investor confidence among the
blue-chip pharmaceutical stocks.
The
results of drug companies were weak during Q4 (Jan-Mar), and inherently the
stocks of these companies are expected to trade negatively for a while now.
For
Q4FY2015 (Jan-Mar), Sun Pharma reported an abysmal performance mainly due to
integration of Ranbaxy Laboratories and the US FDA issues at the Halol facility
which caused the supply constraints in key markets.
